deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT06423794

BHV-7000 Open-Label Extension Bipolar Mania Study

A Phase 2, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of BHV-7000 in Treatment of Bipolar I Disorder

Sponsor: Biohaven Therapeutics Ltd.

Interventions BHV-7000
Updated 7 times since 2024 Last updated: Dec 13, 2025 Started: Jun 24, 2024 Primary completion: Apr 25, 2025 Completion: Apr 25, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Business Decision

Listed as NCT06423794, this PHASE2 trial focuses on Bipolar Disorder and remains terminated or withdrawn. Sponsored by Biohaven Therapeutics Ltd., it has been updated 7 times since 2024, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotEnrolling By Invitation~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotEnrolling By Invitation~Feb 2025 – ~Jul 2025 · 5 months · monthly snapshotEnrolling By Invitation~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshotTerminated~Sep 2025 – ~Jan 2026 · 4 months · monthly snapshotTerminated~Jan 2026 – present · 6 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Jan 2026 — Present [monthly]

    Terminated PHASE2

  2. Sep 2025 — Jan 2026 [monthly]

    Terminated PHASE2

  3. Jul 2025 — Sep 2025 [monthly]

    Terminated PHASE2

    Status: Enrolling By InvitationTerminated

  4. Feb 2025 — Jul 2025 [monthly]

    Enrolling By Invitation PHASE2

  5. Sep 2024 — Feb 2025 [monthly]

    Enrolling By Invitation PHASE2

Show 2 earlier versions
  1. Jul 2024 — Sep 2024 [monthly]

    Enrolling By Invitation PHASE2

    Status: Not Yet RecruitingEnrolling By Invitation

  2. Jun 2024 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Biohaven Therapeutics Ltd.
Data source: Biohaven Pharmaceuticals, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .